Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only

This study has been completed.

Sponsor:

Collaborators:

University of Toronto

Hamilton Health Sciences Corporation

Ontario Ministry of Health and Long Term Care

Information provided by:

West Park Healthcare Centre

ClinicalTrials.gov Identifier:

NCT00546299

First received: October 17, 2007

Last updated: NA

Last verified: October 2007

History: No changes posted

Tracking Information

First Received Date ^ICMJE

October 17, 2007

Last Updated Date

October 17, 2007

Start Date ^ICMJE

February 2003

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

gas usage [ Time Frame: 2 ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only

Official Title ^ICMJE

Ambulatory Gas Usage in Patients With COPD and Exertional Hypoxemia

Brief Summary

Several studies have described the use of supplemental oxygen during exertion or activities of daily living (ambulatory oxygen) in study populations that have different characteristics. This report, based on specialized randomized controlled trials, characterizes ambulatory gas usage among patients with COPD who experience low oxygen levels during activities.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Not Provided

Study Design ^ICMJE

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Treatment

Condition ^ICMJE

Chronic Obstructive Pulmonary Disease

Intervention ^ICMJE

Drug: oxygen

cylinder and concentrator, dosage to maintain SpO2 above 92%, used during exertion

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

December 2005

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Diagnosis of COPD
dyspnea limiting daily activities
desaturation less than or equal to 88% for 2 continuous minutes during a room air six-minute walk test

Exclusion Criteria:

less than or equal to 18 years old
those who met criteria for mortality reduction with long-term oxygen
those who received oxygen for palliative care or isolated nocturnal hypoxemia
those unable to complete the questionnaires or provide informed consent

Gender

Both

Ages

Not Provided

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Not Provided

Administrative Information

NCT Number ^ICMJE

NCT00546299

Other Study ID Numbers ^ICMJE

8-42361

Has Data Monitoring Committee

Responsible Party

Not Provided

Study Sponsor ^ICMJE

West Park Healthcare Centre

Collaborators ^ICMJE

University of Toronto
Hamilton Health Sciences Corporation
Ontario Ministry of Health and Long Term Care

Investigators ^ICMJE

Study Director:

Roger Goldstein, MD

Respiratory Rehabilitation, West Park Healthcare Centre

Information Provided By

West Park Healthcare Centre

Verification Date

October 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top